regulatory
confidence high
sentiment positive
materiality 0.75
Revelation Biosciences regains compliance with Nasdaq stockholders' equity requirement
REVELATION BIOSCIENCES, INC.
- Reported stockholders' equity of $2.67M as of Sep 30, 2024, meeting the $2.5M minimum.
- Entered warrant inducement letters on Dec 3, 2024; 4,064,040 warrants exercised at $1.00/share.
- Gross proceeds from warrant exercises approximately $4.1M; equity now ~$6.0M, cash ~$7.1M.
- Company believes it is compliant with Nasdaq Listing Rule 5550(b)(1) as of Dec 12, 2024.